With the kind of revenue reported this morning this is sure to be a completed acquisition by the end of Q2 The loses can be tolerated since the sales force by the new company will already be in place and will double the amount of product that can be made available to the medical community. Time for this to start heading back to the prices it was at. Ten Cents is on the very near horizon with a lot more to come
Market Data 
Markets 
AI
